Ciox Health Secures $30 Million Investment Led by Merck Global Health Innovation Fund to Advance Digital Patient Clone Platform

On July 25, 2019, VCBeat (WeChat ID: vcbeat) learned that Ciox Health, a provider of clinical data analysis and management platforms, had completed a $30 million financing round, led by Merck’s Global Health Innovation Fund.

Following this round of financing, Ciox Health will accelerate the development of its Digital Patient Clone platform, enhancing its data storage and computational capabilities to reduce healthcare costs and improve patient outcomes.

Ciox Health, headquartered in Georgia, USA, is dedicated to processing various types of clinical data and making them actionable. The company helps clients analyze data by encoding and analyzing patient data from other systems, thereby improving patients' health outcomes. Ciox Health claims it can release, acquire, enhance, and provide medical records and clinical data from anywhere in the United States.

Digital Patient Clone is a health data repository platform launched by Ciox Health in February this year, providing researchers with verified real-world data at scale and on demand. Digital Patient Clone aggregates comprehensive patient data from diverse clinical information systems and standardizes it. Through this platform, pharmaceutical and biotechnology companies can leverage real-world data to develop more innovative therapies.

Pete McCabe, CEO of Ciox Health, stated, “We are honored to fulfill our mission of striving to improve and extend lives.”

“Digital Patient Clone integrates disparate data sources, enabling researchers to make informed clinical decisions using real-world data,” said Julie Krommenhoeck, Vice President of Life Sciences at Ciox Health.

Dr. David Rubin, Managing Director of Merck’s Global Health Innovation Fund, stated: “Ciox Health brings a unique approach to accessing large-scale data. We expect them to work closely with other oncology digital health companies invested in by the Global Health Innovation Fund, thereby driving clinical research and accelerating the launch of new therapies.”

Merck Global Health Innovation Fund (Merck GHI) invests in healthcare companies worldwide through a healthcare ecosystem strategy. This investment approach connects innovative companies with relevant technologies and develops integrated healthcare solutions.

(Compiled by Hu Yifan)